Upgrade

DNA X, Inc.

SONM

Last
$3.63
Day
-4.3%
1y
-70.1%
5y
-99.1%
52w
-77.6%
SPY YTD
+13.3%
XLF
-1.3%
Earnings
2026-10-3020d
EMA 21
3.83
EMA 50
3.74
EMA 200
6.21
20d high
-20.1%
5y high
-99.3%
5y range
0th
Website · 4 employees · United States

Positions held

Your positions

SONM isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
21
Hold
swing
Signal
Buy
Target
$3.83
Stop
$3.32
Stop distance
8.5%
Target vs last
+5.5%

Fundamentals

Market cap$5.65MEnterprise value$7.15MTrailing P/E—Forward P/E4.52
PEG0.25Price / book-4.58Beta1.70Dividend yield0.00%
Revenue growth—Earnings growth—Gross margin0.0%Operating margin54.2%
Profit margin0.0%ROE—ROA-18.7%Debt / equity—
Current ratio0.57Free cash flow-$7.71MAnalyst recommendationnoneMean target—
52w high$16.9752w low$2.52

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue$0.0M$0.0M-$44.1M$16.2M$0.0M—
Op margin——-10.6%-24.5%——
Net income-$1.2M$6.3M-$8.9M-$4.8M-$7.5M—
Gross margin——25.0%11.2%——
Gross profit——-$11.0M$1.8M$0.8M$8.4M
Operating income-$1.3M-$3.6M$4.7M-$4.0M-$1.5M—
  • Gross margin 25% (was 11.2% prior quarter).
  • Operating margin expanded to -10.6%.

Yearly (6y)

20252024202320222021
Revenue$0.0M$0.0M$93.6M$69.8M—
Op margin——0.5%-20.5%—
Net income-$20.7M-$33.6M-$0.1M-$14.1M—
Gross margin——20.6%16.6%—
Gross profit$0.0M$0.0M$19.3M$11.6M—
Operating income-$5.4M-$3.1M$0.5M-$14.3M—
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

SONM · daily-13.6% over 13 sessions
Close EMA21 EMA50 EMA200
3.543.864.174.494.812026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$9M-$3M$4M$10M$16M-25%0%25%2025-Q22025-Q32025-Q42026-Q12026-Q2